These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 9353158

  • 1. Normal human immunoglobulins for intravenous use (IVIg) delay hyperacute xenograft rejection through F(ab')2-mediated anti-complement activity.
    Latremouille C, Genevaz D, Hu MC, Schussler O, Goussef N, Mandet C, Bruneval P, Haeffner-Cavaillon N, Carpentier A, Glotz D.
    Clin Exp Immunol; 1997 Oct; 110(1):122-6. PubMed ID: 9353158
    [Abstract] [Full Text] [Related]

  • 2. Intravenous immunoglobulins for therapeutic use contain anti-idiotypes against xenophile antibodies and prolong discordant graft survival.
    Schussler O, Genevaz D, Latremouille C, Goussev N, Kaveri S, Glotz D.
    Clin Immunol Immunopathol; 1998 Feb; 86(2):183-91. PubMed ID: 9473381
    [Abstract] [Full Text] [Related]

  • 3. Role of Fc fragments in inhibition of xenogenic hyperacute rejection by intravenous immunoglobulin.
    Kojima T, Hayashi S, Yokoyama I, Takagi H.
    Transplantation; 1996 Sep 15; 62(5):559-62. PubMed ID: 8830815
    [Abstract] [Full Text] [Related]

  • 4. The role of natural IgM in the hyperacute rejection of discordant heart xenografts.
    Gambiez L, Salame E, Chereau C, Calmus Y, Cardoso J, Ayani E, Houssin D, Weill B.
    Transplantation; 1992 Oct 15; 54(4):577-83. PubMed ID: 1412747
    [Abstract] [Full Text] [Related]

  • 5. Normal human polyclonal immunoglobulins delay xenograft rejection through distinct F(ab')2 and Fc mediated mechanisms.
    Genevaz D, Latremouille C, Goussev N, Carpentier A, Glotz D.
    Transplant Proc; 1996 Apr 15; 28(2):853-4. PubMed ID: 8623433
    [No Abstract] [Full Text] [Related]

  • 6. Fab fragments from intravenous immunoglobulin prevent hyperacute rejection in the guinea pig-to-rat combination without reducing hemolytic complement activity in rat serum.
    Urbani L, Cardoso J, Soubrane O, Houssin D, Gautreau C.
    Transplant Proc; 2000 Dec 15; 32(8):2707-9. PubMed ID: 11134770
    [No Abstract] [Full Text] [Related]

  • 7. Use of intravenous immunoglobulin to delay xenogeneic hyperacute rejection. An in vivo and in vitro evaluation.
    Gautreau C, Kojima T, Woimant G, Cardoso J, Devillier P, Houssin D.
    Transplantation; 1995 Nov 15; 60(9):903-7. PubMed ID: 7491691
    [Abstract] [Full Text] [Related]

  • 8. Normal human polyclonal immunoglobulins for intravenous use significantly delay hyperacute xenograft rejection.
    Latremouille C, Haeffner-Cavaillon N, Goussef N, Mandet C, Hinglais N, Bruneval P, Bariety J, Carpentier A, Glotz D.
    Transplant Proc; 1994 Jun 15; 26(3):1285. PubMed ID: 8029910
    [No Abstract] [Full Text] [Related]

  • 9. The effect of xenoreactive antibody and B cell depletion on hyperacute rejection of guinea pig-to-rat cardiac xenografts.
    Pruitt SK, Baldwin WM, Barth RN, Sanfilippo F.
    Transplantation; 1993 Dec 15; 56(6):1318-24. PubMed ID: 8278996
    [Abstract] [Full Text] [Related]

  • 10. Natural IgM play a major role in hyperacute rejection of discordant heart xenografts.
    Gambiez L, Salamé E, Chéreau C, Calmus Y, Ayani E, Houssin D, Weill B.
    Transplant Proc; 1992 Apr 15; 24(2):441-2. PubMed ID: 1566380
    [No Abstract] [Full Text] [Related]

  • 11. Predominant role of the Fab fragment in delaying hyperacute rejection in guinea pig-to-rat xenotransplantation.
    Urbani L, Fabre M, Cardoso J, Lambin P, Devillier P, Soubrane O, Houssin D, Gautreau C.
    Transplantation; 1998 Aug 15; 66(3):395-7. PubMed ID: 9721810
    [Abstract] [Full Text] [Related]

  • 12. Beyond hyperacute rejection. Accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets.
    Fryer JP, Leventhal JR, Dalmasso AP, Chen S, Simone PA, Goswitz JJ, Reinsmoen NL, Matas AJ.
    Transplantation; 1995 Jan 27; 59(2):171-6. PubMed ID: 7839436
    [Abstract] [Full Text] [Related]

  • 13. Complement-fixing elicited antibodies are a major component in the pathogenesis of xenograft rejection.
    Miyatake T, Sato K, Takigami K, Koyamada N, Hancock WW, Bazin H, Latinne D, Bach FH, Soares MP.
    J Immunol; 1998 Apr 15; 160(8):4114-23. PubMed ID: 9558123
    [Abstract] [Full Text] [Related]

  • 14. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts.
    Soares M, Lu X, Havaux X, Baranski A, Reding R, Latinne D, Daha M, Lambotte L, Bach FH, Bazin H.
    Transplantation; 1994 Apr 15; 57(7):1003-9. PubMed ID: 8165695
    [Abstract] [Full Text] [Related]

  • 15. [Attempt at preventing hyperacute xenogenic rejection by isotopic suppression of IgM in the recipient].
    Pitre J, Kahan A, Fontaliran P, Houssin D, Weill B.
    Ann Chir; 1996 Apr 15; 50(7):524-31. PubMed ID: 9035421
    [Abstract] [Full Text] [Related]

  • 16. Passive enhancement and hyperacute rejection of renal allografts in the rat.
    Winearls CG, Fabre JW, Hart DN, Millard PR, Morris PJ.
    Transplantation; 1980 Jun 15; 29(6):462-7. PubMed ID: 6996236
    [Abstract] [Full Text] [Related]

  • 17. Role of antibody synthesis and complement activation in concordant xenograft retransplantation.
    Gannedahl G, Karlsson-Parra A, Wallgren A, Roos-Engstrand E, Nilsson B, Tötterman TH, Tufveson G.
    Transplantation; 1994 Aug 15; 58(3):337-44. PubMed ID: 8053058
    [Abstract] [Full Text] [Related]

  • 18. [Superacute xenogenic rejection: attempted treatment with anti-idiotypic antibodies].
    Salamé E, Chereau C, Calmus Y, Ayani E, Houssin D, Weill B.
    Presse Med; 1992 Dec 02; 21(41):1945-6. PubMed ID: 1294946
    [Abstract] [Full Text] [Related]

  • 19. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
    Malassagne B, Calmus Y, Houssin D, Weill B.
    Pathol Biol (Paris); 2000 May 02; 48(4):377-82. PubMed ID: 10868402
    [Abstract] [Full Text] [Related]

  • 20. The effect of soluble complement receptor type 1 on hyperacute xenograft rejection.
    Pruitt SK, Baldwin WM, Marsh HC, Lin SS, Yeh CG, Bollinger RR.
    Transplantation; 1991 Nov 02; 52(5):868-73. PubMed ID: 1949173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.